Legal Opinion
In re Dexilant (Dexlansoprazole) Antitrust Litigation
District Court, N.D. California
Decided September 8, 2026No. 3:25-cv-02785Unknown
1Opinion
1 2 3 4 UNITED STATES DISTRICT COURT 5 NORTHERN DISTRICT OF CALIFORNIA 6 IN RE DEXILANT 7 (DEXLANSOPRAZOLE) ANTITRUST Master Case No. 3:25-cv-02785-JSC LITIGATION 8 ORDER RE: MOTION FOR 9 SANCTIONS 10 Re: Dkt. No. 193 11 12 This antitrust lawsuit arises out of a settlement agreement (“Settlement Agreement”) 13 between the manufacturer of protein pump inhibitor Dexilant and a generics manufacturer. Now 14 before the Court is the motion for sanctions against Plaintiffs brought by Defendants TWi 15 Pharmaceuticals, Inc. and TWi Pharmaceuticals USA, Inc. (“TWi”).1 (Dkt. No. 193.)2 Having 16…
2Cases cited11 opinions
- Chambers v. Nasco, Inc.Supreme Court of the United States · 1991
- Octane Fitness, LLC v. Icon HealthSupreme Court of the United States · 2014
- David M. Fink v. James H. Gomez, Director, Diana Carloni NourseCourt of Appeals for the Ninth Circuit · 2001
- PRIMUS AUTOMOTIVE FINANCIAL SERVICES, INC., Plaintiff-Appellee, v. Rudolph A. BATARSE, Defendant, Jan C. Nielsen, AppellantCourt of Appeals for the Ninth Circuit · 1997
- Christian v. Mattel, Inc.Court of Appeals for the Ninth Circuit · 2002
6 more not listed; retrieve them via the Exa API.